Aptus Pharma Limited's board has approved a proposal to raise funds aggregating up to ₹51 crore for the expansion of its business operations. The decision was taken during a board meeting held on June 12, 2026, at the corporate office in Rajkot, Gujarat. The fund-raising mix includes preferential allotment of securities up to ₹35 crore, debt finance or borrowings up to ₹10 crore, and internal accruals of ₹6 crore.

The preferential allotment will be undertaken in accordance with the Companies Act, 2013, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The board has authorized and delegated authority to Managing Director Tejas Hathi to identify, evaluate, and negotiate with prospective investors. He is also tasked with conducting due diligence and finalizing the details of proposed allottees for placing the matter before the board for final approval.

The board clarified that the resolutions passed are enabling in nature, establishing the maximum ceiling for fund raising. Specific details, including the issue price, number of securities, identity of allottees, and the record date, have not been finalized yet. These material particulars will be deliberated upon and approved at a subsequent board meeting.

The implementation of the preferential allotment is subject to necessary approvals, including a special resolution from shareholders. The company will make a comprehensive disclosure to the stock exchanges in accordance with SEBI LODR Regulations once the board finalizes the specific terms at a later stage.

Aptus Pharma Limited has undertaken a strategic brand-building initiative by taking over the Baby Care Room at Rajkot Hirasar Airport. This move is aimed at promoting the company's upcoming baby care and OTC product portfolio. The initiative was disclosed to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company stated that this premium placement at one of Gujarat's growing airports is designed to enhance brand visibility among travelers and families. By securing this location, Aptus Pharma aims to strengthen awareness of its expanding healthcare product range. The focus is on establishing a stronger presence in the OTC and baby care segment.

Strategic Objectives

The initiative is expected to contribute positively towards the company's brand positioning and market presence. Management believes that the visibility at the airport will aid in improving market reach and strengthening customer trust. The company described the initiative as part of the ordinary course of business.

Operational Divisions

Aptus Pharma operates through several divisions to manage its diverse product portfolio. These divisions include:

The brand promotion at Rajkot Hirasar Airport aligns with the company's broader strategy to expand its footprint in the healthcare and personal care markets.